JF
WHWK

Jump Financial’s Whitehawk Therapeutics WHWK Stock Holding History

Jump Financial’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Buy
+40,800
New +$170K ﹤0.01% 1861
2023
Q2 		– Sell
-20,300
Closed -$147K – 2240
2023
Q1 		$147K Buy
20,300
+9,700
+92% +$104K 0.01% 1374
2022
Q4 		$136K Sell
10,600
-8,700
-45% -$114K 0.01% 1377
2022
Q3 		$273K Buy
+19,300
New +$254K 0.01% 1200

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's WHWK Position: Q2 2026 in Review

Jump Financial opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 40,800 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings. This is a return to the name: Jump Financial previously reported a position in WHWK as recently as Q1 2023.

Jump Financial first reported a position in WHWK in Q3 2022 and has held it in 4 quarters since. The position peaked at $273K in Q3 2022. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Jump Financial held 40,800 shares of Whitehawk Therapeutics worth $187K as of Q2 2026.
  • Whitehawk Therapeutics was a new Jump Financial position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1861 holding.
  • Jump Financial first reported a position in Whitehawk Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • Jump Financial's Whitehawk Therapeutics position peaked at $273K in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.